Startseite Cervical screening in the 21st century: the case for human papillomavirus testing of self-collected specimens
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Cervical screening in the 21st century: the case for human papillomavirus testing of self-collected specimens

  • Brian J. Morris und Barbara R. Rose
Veröffentlicht/Copyright: 7. Mai 2007
Veröffentlichen auch Sie bei De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
Aus der Zeitschrift Band 45 Heft 5

Abstract

Cervical screening by Pap smear involves a high rate of false negatives, necessitating frequent testing. Because women do not like the sampling procedure, many avoid being screened. Testing for the causative high-risk human papillomavirus (HPV) types, by PCR or other technologies, on self-collected (tampon) samples permits women to be monitored non-invasively. The high negative predictive value of HPV testing means a greater interval between tests, and thus reduces costs. HPV testing lends itself to primary screening. A kit for self-collection and return to a testing laboratory, followed by practitioner notification and follow-up if required, should result in wider participation. The higher accuracy of HPV testing should lead to improved cervical cancer prevention.

Clin Chem Lab Med 2007;45:577–91.


Corresponding author: Prof. Brian J. Morris, Basic & Clinical Genomics Laboratory, School of Medical Sciences and Bosch Institute, Building F13, The University of Sydney, NSW 2006, Australia Phone: +61-2-93513688, Fax: +61-2-93512227,

Received: 2006-12-15
Accepted: 2007-2-25
Published Online: 2007-05-07
Published in Print: 2007-05-01

©2007 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. 6th Conference on Homocysteine Metabolism, World Congress on Hyperhomocysteinemia, Saarbruecken/Germany June 5-9, 2007
  2. The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes
  3. Cervical screening in the 21st century: the case for human papillomavirus testing of self-collected specimens
  4. Influence of apolipoprotein E polymorphism on serum lipid and lipoprotein changes: a 21-year follow-up study from childhood to adulthood. The Cardiovascular Risk in Young Finns Study
  5. Association of lipase lipoprotein polymorphisms with myocardial infarction and lipid levels
  6. Validation of a reverse-hybridization StripAssay for the simultaneous analysis of common α-thalassemia point mutations and deletions
  7. HLA-DQA1 and -DQB1 allele typing in southern Taiwanese women with breast cancer
  8. Association of a polymorphism in the promoter of the cellular retinoic acid-binding protein II gene (CRABP2) with increased circulating low-density lipoprotein cholesterol
  9. Frequency of two human glutathione-S-transferase omega-1 polymorphisms (E155 deletion and E208K) in Ovambo and Japanese populations using the PCR-based genotyping method
  10. Transthyretin amyloidosis in a patient of Iranian-Jewish extraction: a second Israeli-Jewish case
  11. Relationship between neurological outcome and early oxidative changes in erythrocytes in head injury patients
  12. Mesothelin family proteins and diagnosis of mesothelioma: analytical evaluation of an automated immunoassay and preliminary clinical results
  13. Prevalence of insulin resistance and prediction of glucose intolerance and type 2 diabetes mellitus in women with polycystic ovary syndrome
  14. A simple high-throughput method for the determination of plasma methylmalonic acid by liquid chromatography-tandem mass spectrometry
  15. Effects of gestational and lactational choline deprivation on brain antioxidant status, acetylcholinesterase, (Na+,K+)- and Mg2+-ATPase activities in offspring rats
  16. Use of novel serum markers in clinical follow-up of Sertoli-Leydig cell tumours
  17. Measurement of calcitonin by immunoassay analyzers
  18. Interference in a homogeneous assay for low-density lipoprotein cholesterol by lipoprotein X
  19. Quality indicators and specifications for key processes in clinical laboratories: a preliminary experience
  20. Analytical and clinical performance of three natriuretic peptide tests in the emergency room
  21. Quality of serum creatinine measurement in light of EQA programs
  22. Decreased plasmalogen concentration as a surrogate marker of oxidative stress in patients presenting with acute coronary syndromes or supraventricular tachycardias
  23. Comparison between AlaTOP and IP8 inhalant panels on the Immulite 2000 analyzer
  24. External quality assessment of urinary methylmalonic acid quantification – results of a pilot study
Heruntergeladen am 16.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2007.127/pdf
Button zum nach oben scrollen